Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

被引:255
作者
Jindani, A
Doré, CJ
Mitchison, DA
机构
[1] St George Hosp, Sch Med, Dept Med Microbiol, London SW17 0RE, England
[2] Int Union TB & Lung Dis, Clin Trials Program, Paris, France
[3] MRC, Clin Trials Unit, London, England
关键词
bactericidal; early bactericidal activity; extended early bactericidal activity; pulmonary tuberculosis; sterilizing;
D O I
10.1164/rccm.200210-1125OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Colony-forming units of Mycobacterium tuberculosis in sputum were counted at 2-day intervals in 100 patients treated with 22 regimens of isoniazid, rifampin, pyrazinamide, ethambutol, or streptomycin, given alone or in combinations. The exponential fall in colonyforming units was measured by linear regression coefficients of the log counts during the initial 2-day phase of rapid, drug-determined killing and during the subsequent 12 days of much slower sterilizing activity. The regression coefficients during the first 2 days varied significantly according to the drug; the greatest effects in multiple regression analyses were due to isoniazid (p < 0.001) and rifampin (p = 0.027). The rapid kill obtained with isoniazid was unaffected by addition of other drugs, so that a change in activity after adding an unknown drug to isoniazid would not be measurable. In multiple regression analysis of the coefficients during Days 2-14, rifampin and streptomycin had significant effects (p = 0.007 and 0.006, respectively), indicating that both drugs had important sterilizing activity, streptomycin particularly early. Isoniazid and pyrazinamide had no significant effects. In analyses of combined drug regimens only, ethambutol had an effect (p = 0.01) in reverse direction to that of rifampin, suggesting it antagonized the sterilizing activity of other drugs.
引用
收藏
页码:1348 / 1354
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 1982, Tubercle, V63, P89
[2]   Foreword from the co-editor-in-chief [J].
Brennan, PJ .
TUBERCULOSIS, 2001, 81 (1-2) :1-1
[3]  
Botha FJH, 1996, S AFR MED J, V86, P155
[4]   Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis [J].
Brindle R. ;
Odhiambo J. ;
Mitchison D. .
BMC Pulmonary Medicine, 1 (1)
[5]  
*BRIT MED RES COUN, 1973, LANCET, V1, P1331
[6]  
*BRIT THOR ASS, 1981, BR J DIS CHEST, V75, P141
[7]  
DICKINSON JM, 1981, AM REV RESPIR DIS, V123, P367
[8]   BACTERICIDAL ACTIVITY OF STREPTOMYCIN, ISONIAZID, RIFAMPIN, ETHAMBUTOL, AND PYRAZINAMIDE ALONE AND IN COMBINATION AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
DICKINSON, JM ;
ABER, VR ;
MITCHISON, DA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1977, 116 (04) :627-635
[9]  
Donald PR, 2002, INT J TUBERC LUNG D, V6, P693
[10]  
Donald PR, 2001, INT J TUBERC LUNG D, V5, P533